Testosterone-Dependent Effects on Protein Biomarkers From Healthy Males

Status Completed

Clinical Trial Summary

The study is designed to identify and validate new protein biomarkers in blood related to testosterone activity. Thirty healthy young males underwent pharmaceutical castration to lower testosterone levels. After three weeks the subjects received an intramuscular injection of testosterone undecanoate. Blood samples from just before pharmaceutical castration, three weeks after castration, and one week after injection of testosterone undecanoate were collected representing normal testosterone levels, low testosterone levels, and testosterone at eugonadal levels.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03541395
Study type	Interventional
Source	Lund University
Contact
Status	Completed
Phase	N/A
Start date	March 2015
Completion date	June 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04467697` - Ambulatory Blood Pressure Monitoring (ABPM) Extension Study of Oral Testosterone Undecanoate in Hypogonadal Men	Phase 3
Completed	`NCT04326673` - Salivary Testosterone in Men: Diurnal Variation and Post-Prandial Responses
Completed	`NCT03203681` - Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters	Phase 4
Completed	`NCT01904734` - Clomid in Men With Low Testosterone With and Without Prior Treatment	Phase 2
Completed	`NCT00400335` - Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride	Phase 1
Completed	`NCT00398580` - 28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men	Phase 2
Recruiting	`NCT05611307` - Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
Completed	`NCT03282682` - Strength Training as a Supplemental Therapy of Androgen Deficiency of the Aging Male	N/A
Terminated	`NCT03335254` - A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males	Phase 1/Phase 2
Terminated	`NCT05205837` - A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS Trial	Phase 4
Completed	`NCT03747003` - Gonadal Function in Young to Middle Aged HIV-infected Men
Withdrawn	`NCT03176537` - Periodontal Profile of Hypogonadic Men	Phase 4
Recruiting	`NCT04049331` - Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone	Phase 2
Recruiting	`NCT05249634` - Testosterone Treatment in Men With Chronic Kidney Disease	Phase 2
Not yet recruiting	`NCT05773183` - Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men
Withdrawn	`NCT04717362` - The Effects of Natesto For Treatment Of Hypogonadism	Early Phase 1
Completed	`NCT05806723` - Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men	Phase 4
Completed	`NCT04456296` - A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism	Phase 4
Not yet recruiting	`NCT06312761` - Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17	Phase 1/Phase 2
Recruiting	`NCT05381831` - Natesto Spermatogenesis Reboot	Phase 4